18 November 2011
Last updated at 22:03
The drug-maker says it will undertake further study to establish which patients will benefit from the drug
US drug regulators have rescinded approval of a breast cancer drug, saying it is not effective enough to justify the risks of taking it.
The drug, Avastin, was approved for US use in 2008, but UK officials have also rejected claims that it
No comments:
Post a Comment